UA36679A - METHOD OF COMPLEX TREATMENT OF ACUTE PYELONEPHRITIS - Google Patents
METHOD OF COMPLEX TREATMENT OF ACUTE PYELONEPHRITISInfo
- Publication number
- UA36679A UA36679A UA2000010409A UA200010409A UA36679A UA 36679 A UA36679 A UA 36679A UA 2000010409 A UA2000010409 A UA 2000010409A UA 200010409 A UA200010409 A UA 200010409A UA 36679 A UA36679 A UA 36679A
- Authority
- UA
- Ukraine
- Prior art keywords
- days
- day
- delivery
- treatment
- spirulina
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Об'єкт винаходу: спосіб комплексного лікування гострого пієлонефриту породіль. 2. Галузь застосування: медицина, точніше акушерство, урологія. 3. Суть винаходу: комплексне лікування включає традиційну антибактеріальну, діуретичну, десенсибілізуючу терапію протягом перших 5-7 днів після пологів. З першого дня після пологів призначають як імуномодулятор препарат спіруліни по 3-5 г на добу перорально. Повний курс лікування спіруліною триває 4-6 місяців з перервами в 10 днів після кожних 20 днів прийому. На другу добу після пологів породіллі одноразово внутрім'язово вводять 1 дозу людського 1-імуноглобуліну. Починаючи з сьомої доби після пологів, призначають курс дезінтоксикаційної терапії за допомогою безперервного мембранного плазмаферезу, який включає 2-3 сеанси з перервами між ними в 4-5 днів. 5. Технічний результат: своєчасна та швидка ліквідація порушень гомеостазу: синдромів системної реакції запалення, ендогенної інтоксикації та, імунодефіциту, 2 з.п. ф-ли, 1 табл., З пр.1. The object of the invention: a method of complex treatment of acute pyelonephritis of women in labor. 2. Field of application: medicine, more precisely obstetrics, urology. 3. The essence of the invention: comprehensive treatment includes traditional antibacterial, diuretic, desensitizing therapy for the first 5-7 days after delivery. From the first day after childbirth is prescribed as an immunomodulator drug spirulina 3-5 g per day orally. The full course of treatment with spirulina lasts 4-6 months with breaks of 10 days after every 20 days. On the second day after delivery, the mother is administered 1 dose of human 1-immunoglobulin once intramuscularly. Starting from the seventh day after delivery, prescribe a course of detoxification therapy using continuous membrane plasmapheresis, which includes 2-3 sessions with intervals of 4-5 days. 5. Technical result: timely and rapid elimination of disorders of homeostasis: syndromes of systemic inflammatory reactions, endogenous intoxication and immunodeficiency, 2 pp f-li, 1 table., With Ave.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA2000010409A UA36679A (en) | 2000-01-25 | 2000-01-25 | METHOD OF COMPLEX TREATMENT OF ACUTE PYELONEPHRITIS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA2000010409A UA36679A (en) | 2000-01-25 | 2000-01-25 | METHOD OF COMPLEX TREATMENT OF ACUTE PYELONEPHRITIS |
Publications (1)
Publication Number | Publication Date |
---|---|
UA36679A true UA36679A (en) | 2001-04-16 |
Family
ID=74181914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA2000010409A UA36679A (en) | 2000-01-25 | 2000-01-25 | METHOD OF COMPLEX TREATMENT OF ACUTE PYELONEPHRITIS |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA36679A (en) |
-
2000
- 2000-01-25 UA UA2000010409A patent/UA36679A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS1694B (en) | Medicinal product for administration to oral animals containing proton pump blockers | |
DE60237363D1 (en) | METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES OF DIGESTIVE STRENGTH WITH TOPIC EFFECTIVE CORTICOSTEROIDS | |
BR9712523A (en) | New heterocyclyl-substituted pyrazole derivatives | |
FR2411821A1 (en) | NEW 1,9-DIHYDROXYOCTAHYDROPHENANTHRENES AND 1-HYDROXYOCTAHYDROPHENANTHRENE-9-ONES AND MEDICINAL PRODUCTS CONTAINING THEM | |
HUP0401867A2 (en) | Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders | |
BR9709838A (en) | Administration regimen that provides a blood plasma profile of an h +, k + -atpase inhibitor oral pharmaceutical composition and the use of h +, k + -atpase inhibitor and processes to improve the inhibition of gastric acid secretion and the therapeutic effect on treatment of gastrointestinal disorders and to receive an extended plasma profile of an h +, k + -atpase inhibitor | |
DE69424777T2 (en) | 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS | |
DE69519933T2 (en) | PROSTAGLANDINANALOGA FOR ORAL OR VAGINAL ADMINISTRATION IN THE ROUTINE TREATMENT OF THE THIRD STAGE OF BIRTH CONSTRUCTION | |
FI971742A (en) | Competitive progesterone antagonists for need-directed degree control in women | |
SE9902597D0 (en) | New use | |
UA36679A (en) | METHOD OF COMPLEX TREATMENT OF ACUTE PYELONEPHRITIS | |
DE68903059T2 (en) | STRONTIUM SALT, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING IT. | |
ATE228843T1 (en) | USE OF DESOXYPEGANINE TO TREAT DRUG DEPENDENCE | |
PT1231908E (en) | PHARMACEUTICAL COMPOSITION UNDERSTANDING A NON-BREAKING COMPOUND AND ITS USE IN THERAPY | |
RU2180591C2 (en) | Agent for treatment of men with sexual disorders | |
HUP0301408A2 (en) | Methods and compositions using sulodexide for the treatment of diabetic nephropathy | |
EP0093497A3 (en) | Anthelmintic treatment | |
ATE275953T1 (en) | 2,3 DIARYL-1-BENZOPYRAMES FOR THE TREATMENT OF DERMATITIS | |
SE9904424D0 (en) | Use of interleukin-6 in combination with leptin in the treatment of obesity | |
DE69428797T2 (en) | USE OF BENZYDAMINE TO TREAT DISEASES CAUSED BY TNF | |
HUP9800623A2 (en) | Application of (+)-o-demethyl-tramadol for production of oral analgesic pharmaceutical compositions | |
RU2000102226A (en) | METHOD FOR INTEGRATED TREATMENT OF ACUTE PYELONEPHRITIS | |
WO2023150579A3 (en) | Pharmaceutical formulations containing nalbuphine | |
RU2189812C2 (en) | Method for treating the cold trauma | |
UA42194A (en) | METHOD OF ADMINISTRATION OF MEDICINAL PRODUCTS CONCENTRATED IN ERYTHROCYTIC CONTAINERS |